Rigosertib promotes anti-tumor immunity via autophagic degradation of PD-L1 in colorectal cancer cellsXinyi Zhou(Wuhan University), Qian Xiao(Zhejiang Cancer Hospital)bioRxiv (Cold Spring Harbor Laboratory)February 8, 202310.1101/2023.02.07.527284Cited by 1SaveCiteExport RISWatch citationsRelated PapersIdentification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome|Genome Medicine|2023|178BEX1 Promotes Imatinib-Induced Apoptosis by Binding to and Antagonizing BCL-2|PLoS ONE|2014|26Manipulating electron extraction efficiency in microbial electrochemical carbon fixation via single-atom engineering|Materials Today|2023|13